Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Pharmacovigilance Outsourcing Market Forecast Highlighting Growth From $8.51 Billion To $16.08 Billion
In recent years, the pharmacovigilance outsourcing market has seen substantial growth. Valued at $7.24 billion in 2025, it is projected to expand to $8.51 billion by 2026, delivering a compound annual growth rate (CAGR) of 17.6%. This historic momentum has been driven by several key factors, including a higher volume of new drug approvals, a growing recognition of pharmacovigilance’s importance among pharmaceutical firms, a shortage of internal pharmacovigilance expertise, tighter regulatory oversight, and the broadening scope of clinical trial activities worldwide.
The pharmacovigilance outsourcing market is anticipated to experience robust expansion over the coming years. By 2030, it is projected to reach a value of $16.09 billion, advancing at a compound annual growth rate (CAGR) of 17.2%. This upward trajectory in the forecast period can be linked to several factors, including the incorporation of artificial intelligence and data analytics into pharmacovigilance processes, heightened reliance on contract research organizations (CROs) and business process outsourcing (BPO) firms, the growing use of cloud-based platforms for safety monitoring, broader global mandates for safety reporting, and increased funding for IT infrastructure and technological tools. Key developments shaping this period involve a stronger trend toward pharma companies adopting outsourced safety services, stricter regulatory demands and evolving reporting benchmarks, greater automation in detecting and processing adverse drug reactions, improved integration of knowledge management and data solutions, along with a growing emphasis on risk mitigation and quality assurance initiatives.
Download A Free Sample Report For Comprehensive Market Insights:
Pharmacovigilance Outsourcing Market Opportunity Drivers: What Is Creating New Revenue Potential?
An expanding volume of clinical studies is anticipated to drive future growth in the pharmacovigilance outsourcing market. These studies, which assess new drugs, treatments, or medical devices for their safety, effectiveness, and possible adverse effects, are becoming more prevalent due to factors such as an intensified emphasis on precision medicine, a growing prevalence of chronic conditions, supportive regulatory frameworks, and the worldwide expansion of research activities. By utilizing specialized expertise and resources within clinical trials, pharmacovigilance outsourcing strengthens drug safety monitoring, facilitates adherence to regulatory standards, and boosts operational efficiency. As an illustration, data from December 2024 released by the Association of the British Pharmaceutical Industry (ABPI), a UK-based trade organization, indicates that the number of industry-led clinical trials launched in the United Kingdom rose to 426 in 2023, compared to 411 in 2022. Consequently, this upward trend in clinical trial numbers is fueling the expansion of the pharmacovigilance outsourcing market.
Pharmacovigilance Outsourcing Market Categorization By Product Type And Application
The pharmacovigilance outsourcing market covered in this report is segmented –
1) By Type: Adverse Drug Reaction Capture (ADR), Case Processing, Reporting And Submission, Report Publishing, Quality Check, Risk Management, Knowledge Management, Enabling Architecture
2) By Service Provider: Contract Research Organization, Business Processing Outsourcing
3) By End User: Pharmaceutical Industry, Research Organization, Other End Users
Subsegments:
1) By Adverse Drug Reaction Capture (ADR): Automated ADR Reporting Tools, Manual ADR Reporting Solutions, ADR Data Mining Software
2) By Case Processing: Case Intake and Triage Services, Medical Review and Evaluation Services, Data Entry and Management Services
3) By Reporting And Submission: Regulatory Reporting Services, Submission to Health Authorities, Compliance Tracking Services
4) By Report Publishing: Clinical Study Report Publishing, Safety Update Report Publishing, Final Study Report Publishing
5) By Quality Check: Quality Assurance Services, Audit and Inspection Services, Compliance Monitoring Services
6) By Risk Management: Risk Assessment Services, Risk Minimization Strategies, Benefit-Risk Evaluation Services
7) By Knowledge Management: Data Management Solutions, Pharmacovigilance Database Management, Knowledge Sharing Platforms
8) By Enabling Architecture: IT Infrastructure Solutions, Data Integration Services, Technology Platform Support
Pharmacovigilance Outsourcing Market Innovation Trends Driving Future Development
Key players within the pharmacovigilance outsourcing market are prioritizing the development of cutting-edge tools like cloud-based data lake platforms to improve case processing and safety data management, with the aim of advancing clinical research registries and satisfying regulatory standards. A cloud-based data lake platform functions as a centralized storage system that enables the handling of substantial volumes of raw data while preserving its original format until necessary. In December 2023, Thermo Fisher Scientific Inc., a biotechnology and laboratory equipment provider headquartered in the United States, introduced CorEvidence with the goal of boosting clinical research registries. This solution is intended to facilitate pharmacovigilance case processing by integrating diverse data sources and enhancing the coding, classification, and reporting of adverse events. Its importance is derived from its capacity to deliver scalable, compliant, and auditable safety management, strengthen CorEvitas clinical research registries, and sustain long-term post-authorization safety studies across multiple therapeutic fields.
Pharmacovigilance Outsourcing Market Company Landscape And Strategic Competition
Major companies operating in the pharmacovigilance outsourcing market are ACCENTURE PLC, International Business Machines Corporation (IBM), Tata Consultancy Services, Capgemini SE, Cognizant Technology Solutions Corporation, IQVIA Holdings Inc., Wipro Limited, ICON PLC, Syneos Health, Genpact limited, Parexel International Corp, Veeva Systems Inc., Medpace Holdings Inc., ProPharma Group, Pharmalex GmbH, PrimeVigilance Ltd., Veristat LLC, United BioSource LLC, Lambda Therapeutic Research, ArisGlobal, Biomapas
Access The Complete Pharmacovigilance Outsourcing Market Report:
Pharmacovigilance Outsourcing Market Geographic Analysis: Where Is Demand Growing The Fastest?
North America was the largest region in the pharmacovigilance outsourcing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmacovigilance outsourcing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model